Cheelcare Income Statement

Financials in millions CAD. Fiscal year is May - April.

Millions CAD. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023
Revenue	1.91	1.57	1.44	1.11
Revenue Growth	21.60%	9.22%	29.47%	-
Cost of Revenue	1.44	0.91	0.67	0.53
Gross Profit	0.46	0.66	0.77	0.58
Selling, General & Admin	1.73	1.17	0.94	0.51
Research & Development	0.58	0.17	0.14	0.13
Operating Expenses	2.78	1.71	1.08	0.65
Operating Income	-2.32	-1.05	-0.31	-0.06
Interest Expense	-0.38	-0.28	-0.19	-0.16
Other Non Operating Income (Expenses)	-1.85	0.06	-0.04	0.09
EBT Excluding Unusual Items	-4.55	-1.27	-0.54	-0.13
Other Unusual Items	-0.31	-	-	-
Pretax Income	-4.86	-1.27	-0.54	-0.13
Net Income	-4.86	-1.27	-0.54	-0.13
Net Income to Common	-4.86	-1.27	-0.54	-0.13
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	18	11	3	-
Shares Outstanding (Diluted)	18	11	3	-
Shares Change	70.74%	296.50%	-	-
EPS (Basic)	-0.27	-0.12	-0.20	-
EPS (Diluted)	-0.27	-0.12	-0.20	-
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023
Free Cash Flow	-3.72	-0.51	-0.21	-0.03
Free Cash Flow Per Share	-0.21	-0.05	-0.08	-
Gross Margin	24.33%	42.29%	53.67%	52.67%
Operating Margin	-121.30%	-66.61%	-21.60%	-5.65%
Profit Margin	-254.56%	-80.90%	-37.63%	-11.39%
Free Cash Flow Margin	-194.64%	-32.18%	-14.80%	-2.69%
EBITDA	-2.28	-1	-0.31	-0.06
EBITDA Margin	-119.63%	-63.68%	-21.33%	-5.17%
D&A For EBITDA	0.03	0.05	0	0.01
EBIT	-2.32	-1.05	-0.31	-0.06
EBIT Margin	-121.30%	-66.61%	-21.60%	-5.65%
Revenue as Reported	-	-	-	1.11
Advertising Expenses	0.07	0.01	0.06	0.08